Daiwa Securities Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
VPM
VCM
DTC
Daiwa Securities Group's AXSM Position: Q1 2026 in Review
Daiwa Securities Group sold out of Axsome Therapeutics (AXSM) in Q1 2026, closing a stake of 145 shares — an estimated $26K sold.
Daiwa Securities Group first reported a position in AXSM in Q4 2019 and held it in 25 quarters. The position peaked at $26K in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.
- Daiwa Securities Group reported no remaining Axsome Therapeutics position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 145 Axsome Therapeutics shares in Q1 2026, an estimated $26K.
- Daiwa Securities Group first reported a position in Axsome Therapeutics in Q4 2019 and held it in 25 quarters.
- Daiwa Securities Group's Axsome Therapeutics position peaked at $26K in Q4 2025.
- 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.